Burnet’s Stellabody® technology exploits a natural antibody behaviour to facilitate the formation of hexamers. This enhances the action of antibodies and related biologics.
Our Immune Therapies group is an internationally recognised laboratory in antibody immune function and has significant expertise to transform antibody assets into a potent and efficacious therapeutic for treating cancer, autoimmune disease and infection.
This flyer contains information about Stellabody® technology’s on-target hexamerisation, our Immune Therapies group’s capabilities, and our fee-for-service work.